WallStSmart

Corteva Inc (CTVA)vsICL Israel Chemicals Ltd (ICL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Corteva Inc generates 141% more annual revenue ($17.89B vs $7.41B). CTVA leads profitability with a 6.5% profit margin vs 3.5%. CTVA appears more attractively valued with a PEG of 1.27. CTVA earns a higher WallStSmart Score of 64/100 (C+).

CTVA

Buy

64

out of 100

Grade: C+

Growth: 4.7Profit: 5.5Value: 4.0Quality: 6.0
Piotroski: 4/9Altman Z: 1.49

ICL

Buy

59

out of 100

Grade: C

Growth: 6.0Profit: 5.0Value: 3.3Quality: 5.5
Piotroski: 2/9Altman Z: 2.12
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CTVASignificantly Overvalued (-73.4%)

Margin of Safety

-73.4%

Fair Value

$44.32

Current Price

$77.46

$33.14 premium

UndervaluedFair: $44.32Overvalued
ICLSignificantly Overvalued (-24.5%)

Margin of Safety

-24.5%

Fair Value

$4.62

Current Price

$5.60

$0.98 premium

UndervaluedFair: $4.62Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CTVA4 strengths · Avg: 8.5/10
Market CapQuality
$50.64B9/10

Large-cap with strong market position

Debt/EquityHealth
0.149/10

Conservative balance sheet, low leverage

Price/BookValuation
2.1x8/10

Reasonable price relative to book value

Operating MarginProfitability
23.7%8/10

Strong operational efficiency at 23.7%

ICL2 strengths · Avg: 9.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

EPS GrowthGrowth
39.5%8/10

Earnings expanding 39.5% YoY

Areas to Watch

CTVA4 concerns · Avg: 2.5/10
Return on EquityProfitability
4.8%3/10

ROE of 4.8% — below average capital efficiency

Profit MarginProfitability
6.5%3/10

6.5% margin — thin

P/E RatioValuation
40.9x2/10

Premium valuation, high expectations priced in

Free Cash FlowQuality
$-2.97B2/10

Negative free cash flow — burning cash

ICL4 concerns · Avg: 3.3/10
P/E RatioValuation
26.6x4/10

Moderate valuation

Return on EquityProfitability
4.3%3/10

ROE of 4.3% — below average capital efficiency

Profit MarginProfitability
3.5%3/10

3.5% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : CTVA

The strongest argument for CTVA centers on Market Cap, Debt/Equity, Price/Book. Revenue growth of 11.0% demonstrates continued momentum. PEG of 1.27 suggests the stock is reasonably priced for its growth.

Bull Case : ICL

The strongest argument for ICL centers on Price/Book, EPS Growth. Revenue growth of 14.5% demonstrates continued momentum.

Bear Case : CTVA

The primary concerns for CTVA are Return on Equity, Profit Margin, P/E Ratio. A P/E of 40.9x leaves little room for execution misses.

Bear Case : ICL

The primary concerns for ICL are P/E Ratio, Return on Equity, Profit Margin. Thin 3.5% margins leave little buffer for downturns.

Key Dynamics to Monitor

ICL carries more volatility with a beta of 0.95 — expect wider price swings.

ICL is growing revenue faster at 14.5% — sustainability is the question.

ICL generates stronger free cash flow (45M), providing more financial flexibility.

Monitor AGRICULTURAL INPUTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CTVA scores higher overall (64/100 vs 59/100) and 11.0% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Corteva Inc

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Corteva, Inc. (also known as Corteva Agriscience) is a major American agricultural chemical and seed company that was the agricultural unit of DowDuPont prior to being spun off as an independent public company.

Visit Website →

ICL Israel Chemicals Ltd

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

ICL Group Ltd, is a company specialized in minerals and chemical products worldwide. The company is headquartered in Tel Aviv, Israel.

Visit Website →

Want to dig deeper into these stocks?